Industry News
Interim results: Moderna vaccine candidate stable and effective
Interim analysis of Moderna's Phase 3 study of mRNA-1273 finds that the COVID-19 vaccine candidate has an efficacy of 94.5% and remains stable at -20°C for up to six months. [ + ]
BD supplies COVID-19 consumables in milestone delivery
BD will deliver millions of disposable needles, syringes and sharps collectors over the next 12 months, to support Australia's COVID-19 Vaccine and Treatment Strategy. [ + ]
Seqirus to build $800m flu vaccine facility in Melbourne
Seqirus has announced plans to construct a world-class biotech manufacturing facility in Australia to supply influenza vaccines to Australia and the rest of the world. [ + ]
Drink slows disease progression in early-stage Alzheimer's
A nutritional drink has been found to slow the decline of cognition, function, brain atrophy and disease progression in patients with mild cognitive impairment. [ + ]
Report highlights value of preventing and reducing stroke
A Stroke Foundation report has found that preventing stroke and improving access to treatment and care could save thousands of lives and billions of dollars each year. [ + ]
Pregnant and postpartum women with COVID-19 are at risk of blood clotting
Pregnant women who contract COVID-19 may be at higher risk of blood clotting, especially those who become severely ill with the virus, says Associate Professor Sanjaya Senanayake of the Australian National University. [ + ]
How did Royal Melbourne Hospital curb its COVID-19 outbreak?
Reported to have endured the largest institutional outbreak of COVID-19 in healthcare workers in Australia, the RMH's multidimensional response has been examined. [ + ]
CSIRO solution creates smarter, safer homes for independent seniors
CSIRO has developed a new health monitoring solution that will enable older Australians living independently at home to send real-time data to their healthcare providers. [ + ]
Autism interventions published in landmark report
Autism CRC has published a landmark report, detailing the best available high-quality evidence about interventions for children on the autism spectrum aged up to 12 years. [ + ]
Partners take on cancer and heart disease
GE Healthcare and GenesisCare have partnered to tackle the globe's greatest health burdens: cancer and cardiovascular disease. [ + ]
Research uncovers the hidden path of breast cancers
The secret pathway used by some aggressive breast cancers to avoid detection has been uncovered by researchers at Macquarie University. [ + ]
New technique stimulates relief for chronic pain sufferers
A multicentre randomised controlled trial has demonstrated the importance of a new spinal cord stimulation technique in providing back pain relief compared with conventional therapy. [ + ]
Double win for Australian Mental Health Prize
Scientia Professor Gordon Parker and Professor Helen Milroy have been announced as dual winners of the 2020 Australian Mental Health Prize. [ + ]
Wavelink announces Olinqua's hospital communication solution
Enterprise solutions provider Wavelink has announced the availability of Olinqua's mobile communication application for hospitals. [ + ]
School poisoning incidence calls for improved safety
Child and adolescent exposure to poisoning while at school is relatively common and appears to be increasing, according to research from the University of Sydney. [ + ]